Interactive Voice Based Administration of the GAD 7

Oklahoma State University Center for Health Sciences

Status: Unknown

Conditions: General Anxiety Disorder

Treatments: Diagnostic Test: Voice Administered GAD 7; Diagnostic Test: Paper GAD 7

Study type: Interventional

Funder types: Other

Identifiers

NCT04990492

2021029

Details and patient eligibility

About

This study investigates a new delivery method for the General Anxiety Disorder - 7 (GAD 7), a clinically accepted tool for diagnosing general anxiety disorder. The new tool records auditory responses to the assessment and the study will examine if the instrument is effective at capturing participant depression levels. If proven effective, future studies may investigate if the new format can be used to improve at home clinical care.

Full description

This study is an investigation of the construct validity and user experience of a new delivery system for the General Anxiety Disorder - 7 (GAD 7), a clinically accepted tool for diagnosing general anxiety disorder. The purpose of the study is to examine if the new delivery system of the GAD 7 is effective at capturing participant anxiety levels and to assess the differences of usability between the paper and voice administered versions. The voice administered version uses a Mirror device, which is similar to a smart television with a mirror interface. The device records auditory responses to the GAD 7 through Amazon Alexa. The investigators will be comparing the responses on the new device to those given on the clinically established paper format. If proven effective at capturing depression levels of patients, future studies may investigate if the new format can be used to improve at home clinical care.

Enrollment: 40 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria::

• Newly admitted patients to the Oklahoma State University Behavioral Medicine Clinic

Exclusion Criteria:

• Vulnerable populations, such as children (i.e., minors or individuals under the legal age of consent) and individuals who are incarcerated (i.e., prisoners), will be excluded.
• Individuals who are not their own guardian (i.e., those suffering from severe disabilities) will also be excluded.

Trial design

Primary purpose: Diagnostic

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: None (Open label)

---

40 participants in 2 patient groups

Paper Baseline

Experimental group

Description:

Half of the participants will complete the GAD 7 in the traditional paper format at their first appointment. At their second appointment 1-month later, they will complete the GAD 7 on the Mirror device equipped with Amazon Alexa.

Treatment:

Diagnostic Test: Paper GAD 7

Diagnostic Test: Voice Administered GAD 7

Alexa Baseline

Experimental group

Description:

The other half of the participants will complete the GAD 7 on the Mirror device equipped with Amazon in the traditional paper format at their first appointment. At their second appointment 1-month later, they will complete the GAD 7 in the traditional paper format.

Treatment:

Diagnostic Test: Paper GAD 7

Diagnostic Test: Voice Administered GAD 7